The over expression and/or mutation of EGFR tyrosine kinase has been observed in many human solid tumors, including non-small cell lung, breast, ovarian and squamous cell cancers [2,3,4,5], EGFR has been under intense investigation as a novel anticancer molecular target [6]. Here, EGFR is linked to squamous cell carcinoma.